Home > Boards > US Listed > Biotechs > Portola Phramaceuticals (PTLA)

I would not be surprised if there is

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Valsartan160 Member Profile
 
Followed By 0
Posts 11
Boards Moderated 0
Alias Born 10/02/18
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 4:49:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2019 5:07:23 PM
Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences GlobeNewswire Inc. - 5/28/2019 4:30:00 PM
Portola Pharmaceuticals Announces New Analysis from the ANNEXA-4 Study of its Factor Xa Inhibitor Reversal Agent Andexxa® i... GlobeNewswire Inc. - 5/22/2019 10:45:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/8/2019 8:38:16 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2019 8:07:58 AM
Portola Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 5/8/2019 8:01:00 AM
European Commission Grants Conditional Marketing Authorization for Portola Pharmaceuticals’ Ondexxya™ (andexanet alfa), t... GlobeNewswire Inc. - 4/26/2019 2:00:47 PM
European Commission Grants Conditional Marketing Authorization for Portola Pharmaceuticals’ Ondexxya™ (andexanet alfa), t... GlobeNewswire Inc. - 4/26/2019 2:00:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/25/2019 11:21:27 AM
Portola Pharmaceuticals Announces Retirement of Dr. John Curnutte, Executive Vice President and Head of Research and Developm... GlobeNewswire Inc. - 4/24/2019 8:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/22/2019 6:03:30 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/22/2019 6:03:24 AM
Portola Pharmaceuticals to Announce First Quarter 2019 Financial Results on Wednesday, May 8, 2019 GlobeNewswire Inc. - 4/17/2019 4:15:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/16/2019 7:45:27 PM
New Research: Key Drivers of Growth for Newmont Mining, Johnson & Johnson, Portola Pharmaceuticals, MedEquities Realty Trust,... GlobeNewswire Inc. - 4/10/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/8/2019 7:04:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/1/2019 7:28:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/20/2019 5:13:15 PM
Portola Pharmaceuticals’ Co-Founder Dr. Charles Homcy Retires from the Company’s Board of Directors GlobeNewswire Inc. - 3/20/2019 5:00:00 PM
Portola Pharmaceuticals to Webcast Presentation at Cowen and Company’s 39th Annual Health Care Conference GlobeNewswire Inc. - 3/6/2019 4:10:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/5/2019 6:32:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/5/2019 6:28:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/5/2019 6:22:29 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/1/2019 2:52:14 PM
Valsartan160   Saturday, 11/17/18 03:25:59 AM
Re: H2R post# 150
Post # of 178 
I would not be surprised if there is an early approval.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist